Trial Profile
Nilotinib treatment; effects on cholesterol and triglyceride levels in patients with chronic-phase chronic myeloid leukaemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2014
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics
- 08 Sep 2014 New trial record